← Back to Patent Explorer
US4444782A Expired / Lapsed US ⏱️ 0.0 years remaining

2(4-tert.-Butyl-2,6-dichlorophenyl-imino)imidazolidine and use as an anti-hypertension agent

Assignee: SmithKline Beecham Corp
•
Filing: 1982-12-23
•
Granted: 1984-04-24
•
Expires: 2002-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-(4-tert.-Butyl-2,6-dichlorophenylimino)imidazolidine is a anti-hypertensive chemical compound which has unexpected biological properties compared to those of clonidine.

Inventors

  • 👤 Robert M. DeMarinis
  • 👤 J. Paul Hieble

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 11:56
CPC Classifications
C; C07; C07C; C07C331/00; C07C331/16; C07C331/28; A; A61; A61P; A61P9/00; A61P9/12; C07D; C07D233/00; C07D233/04; C07D233/28; C07D233/44; C07D233/50

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 7 words
2-(4-tert.-Butyl-2,6-dichlorophenylimino)imidazolidine or its pharmaceutically acceptable addition salts.
Claim 2
Dependent Claim 7 words
2-(4-tert.-Butyl-2,6-dichlorophenylimino)imidazolidine or its pharmaceutically acceptable addition salts.
Claim 3
Dependent Claim 10 words
The compound of claim 1 being 2-(4-tert.-butyl-2,6-dichlorophenylimino)imidazolidine as the base.
Claim 4
Dependent Claim 8 words
The compound of claim 1 being 2-(4-tert.-butyl-2,6-dichlorophenylimino)imidazolidine hydrochloride.
Claim 5
Dependent Claim 27 words
A pharmaceutical composition having anti-hypertensive activity comprising a nontoxic, anti-hypertensively effective quantity of a compound of claim 1 combined with a pharmaceutical carrier in dosage unit form.
Claim 6
Dependent Claim 34 words
The method of inducing antihypertensive activity in a subject in need thereof without excess sedation comprising administering to said subject, orally, anally or parenterally, an antihypertensive, nontoxic quantity of a compound of claim 1.

References Cited (Backward Citations)

US3236857A Cited
US3454701A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-04-24 1987-10-24 1988-04-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-04-24 1991-10-24 1992-04-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-04-24 1995-10-24 1996-04-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag